Literature DB >> 15354388

Differential executive control impairments in early Parkinson's disease.

J Uekermann1, I Daum, M Bielawski, S Muhlack, S Peters, H Przuntek, T Mueller.   

Abstract

Investigations concerning cognitive functions in early PD have revealed memory and executive function deficits related to dysfunction of fronto-striatal circuitry. Despite the range of data base, many previous investigations are limited because of methodological questions and inconsistencies. Thus the pattern of executive function impairments in early PD is far from being established. In the present investigation, twenty PD patients in early stages of the disease were compared to control subjects on a comprehensive neuropsychological test battery, aiming to explore their cognitive profile across a range of executive subcomponents. Results revealed impairments with respect to initiation, reasoning and planning. In summary, the present investigation shows that PD is associated with a differential executive impairment pattern which is (partly) related to disease characteristics and affective variables.

Entities:  

Mesh:

Year:  2004        PMID: 15354388     DOI: 10.1007/978-3-7091-0579-5_5

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

2.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

3.  Impairment of script comprehension in Lewy body spectrum disorders.

Authors:  Rachel G Gross; Emily Camp; Corey T McMillan; Michael Dreyfuss; Delani Gunawardena; Philip A Cook; Brianna Morgan; Andrew Siderowf; Howard I Hurtig; Matthew B Stern; Murray Grossman
Journal:  Brain Lang       Date:  2013-04-06       Impact factor: 2.381

4.  A common cognitive profile in elderly fallers and in patients with Parkinson's disease: the prominence of impaired executive function and attention.

Authors:  Jeffrey M Hausdorff; Glen M Doniger; Shmuel Springer; Galit Yogev; Ely S Simon; Nir Giladi
Journal:  Exp Aging Res       Date:  2006 Oct-Dec       Impact factor: 1.645

5.  Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation.

Authors:  Uyen Ha Gia Pham; Stein Andersson; Mathias Toft; Are Hugo Pripp; Ane Eidahl Konglund; Espen Dietrichs; Ulrik Fredrik Malt; Inger Marie Skogseid; Ira Ronit Hebolt Haraldsen; Anne-Kristin Solbakk
Journal:  Parkinsons Dis       Date:  2015-06-18

6.  Cognitive Function and Postural Control Strategies in Relation to Disease Progression in Patients with Parkinson's Disease.

Authors:  Monika Zawadka-Kunikowska; Jacek J Klawe; Małgorzata Tafil-Klawe; Monika Bejtka; Łukasz Rzepiński; Mirosława Cieślicka
Journal:  Int J Environ Res Public Health       Date:  2022-10-04       Impact factor: 4.614

7.  Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy.

Authors:  Jennifer A Foley; Elaine H Niven; Andrew Paget; Kailash P Bhatia; Simon F Farmer; Paul R Jarman; Patricia Limousin; Thomas T Warner; Huw R Morris; Thomas H Bak; Sharon Abrahams; Lisa Cipolotti
Journal:  Parkinsons Dis       Date:  2018-05-09

8.  Alternate fluency in Parkinson's disease: A machine learning analysis.

Authors:  Roberta Ferrucci; Francesca Mameli; Fabiana Ruggiero; Mariella Reitano; Mario Miccoli; Angelo Gemignani; Ciro Conversano; Michelangelo Dini; Stefano Zago; Silvie Piacentini; Barbara Poletti; Alberto Priori; Graziella Orrù
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.